Kevin Bowrin
5PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Aug 23, 2022
Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis.Carina Blomström Lundqvist, Sara Själander, Luis A Garcia Rodriguez
|Jul 08, 2022
Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies.Olivia Wu, Stephen Morris, Torben Bjerregaard Larsen
|Nov 09, 2021
Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands.J A Spoorendonk, J-B Briere, K Bowrin
|Sep 09, 2021
Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-Analysis.Rupert Bauersachs, Olivia Wu, Neil Hawkins
|Jan 25, 2020
Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France.Kevin Bowrin, Jean-Baptiste Briere, Laurent Fauchier
Pageof 1
Frequent Collaborators
2 joint publications
Olivia Wu
2 joint publications
Piotr Wojciechowski
2 joint publications
Maria Huelsebeck
1 joint publications
J-B Briere
1 joint publications
Rupert Bauersachs
1 joint publications
Neil Hawkins
1 joint publications
Emilie Clay
1 joint publications
Stephen Morris
1 joint publications
Torben Bjerregaard Larsen
1 joint publications
Flemming Skjøth
